Abstract
The in vitro antibacterial activity of cefotaxime, cefepime and cefpirome was evaluated alone and in association with two beta-lactamase inhibitors: clavulanic acid and sulbactam against 65 extended broad spectrum beta-lactamase producing enterobacteriaceae strains [Klebsiella pneumoniae (35), Proteus mirabilis (9), Escherichia coli (11), Enterobacter aerogenes (10)]. The lowest MICs were observed for cefepime and cefpirome used alone. In association with inhibitors cefotaxime was less effective against E. aerogenes. Most isolates of K. pneumoniae, P. mirabilis, E. coli were susceptible to all the different tested associations.
MeSH terms
-
Cephalosporins / administration & dosage
-
Cephalosporins / pharmacology*
-
Drug Therapy, Combination / pharmacology*
-
Enterobacter / classification
-
Enterobacter / drug effects*
-
Enterobacter / enzymology
-
Enzyme Inhibitors / administration & dosage
-
Enzyme Inhibitors / pharmacology*
-
Escherichia coli / drug effects
-
Escherichia coli / enzymology
-
In Vitro Techniques
-
Klebsiella pneumoniae / drug effects
-
Klebsiella pneumoniae / enzymology
-
Microbial Sensitivity Tests
-
Proteus mirabilis / drug effects
-
Proteus mirabilis / enzymology
-
beta-Lactamase Inhibitors*
-
beta-Lactamases / metabolism
Substances
-
Cephalosporins
-
Enzyme Inhibitors
-
beta-Lactamase Inhibitors
-
beta-Lactamases